These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20141580)

  • 1. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy.
    Galanaud JP; Cochery-Nouvellon E; Alonso S; Chauleur C; Mercier E; Lissalde-Lavigne G; Fabbro-Peray P; Reny JL; Mares P; Dauzat M; Quere I; Gris JC
    J Thromb Haemost; 2010 Apr; 8(4):707-13. PubMed ID: 20141580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The A6936G polymorphism of the endothelial protein C receptor gene is associated with the risk of unexplained foetal loss in Mediterranean European couples.
    Cochery-Nouvellon E; Chauleur C; Demattei C; Mercier E; Fabbro-Peray P; Marès P; Mismetti P; Lissalde-Lavigne G; Gris JC
    Thromb Haemost; 2009 Oct; 102(4):656-67. PubMed ID: 19806250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
    Renner W; Köppel H; Hoffmann C; Schallmoser K; Stanger O; Toplak H; Wascher TC; Pilger E
    Thromb Res; 2000 Jul; 99(1):35-9. PubMed ID: 10904101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of two haplotypes of the human endothelial protein C receptor gene.
    Medina P; Navarro S; Bonet E; Martos L; Estellés A; Bertina RM; Vos HL; España F
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):684-90. PubMed ID: 24436369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy.
    Cochery-Nouvellon E; Mercier E; Lissalde-Lavigne G; Daurès JP; Quéré I; Dauzat M; Marès P; Gris JC
    J Thromb Haemost; 2007 Apr; 5(4):700-7. PubMed ID: 17408404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain].
    Francès F; Portolès O; Gabriel F; Corella D; Sorlí JV; Sabater A; Alfonso JL; Guillén M
    Rev Med Chil; 2006 Jan; 134(1):13-20. PubMed ID: 16532157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
    Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
    Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation.
    Navarro S; Medina P; Mira Y; Estellés A; Villa P; Ferrando F; Vayá A; Bertina RM; España F
    Haematologica; 2008 Jun; 93(6):885-91. PubMed ID: 18403391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
    Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
    BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of F5 1691G>A, F2 20210G>A, and MTHFR 677C>T polymorphisms in Bosnian women with pregnancy loss.
    Mahmutbegović E; Marjanović D; Medjedović E; Mahmutbegović N; Dogan S; Valjevac A; Czerska E; Pawińska-Matecka A; Madlani A; Adler G
    Bosn J Basic Med Sci; 2017 Nov; 17(4):309-314. PubMed ID: 28488549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.
    Stacey D; Chen L; Stanczyk PJ; Howson JMM; Mason AM; Burgess S; MacDonald S; Langdown J; McKinney H; Downes K; Farahi N; Peters JE; Basu S; Pankow JS; Tang W; Pankratz N; Sabater-Lleal M; de Vries PS; Smith NL; ; Gelinas AD; Schneider DJ; Janjic N; Samani NJ; Ye S; Summers C; Chilvers ER; Danesh J; Paul DS
    Nat Commun; 2022 Mar; 13(1):1222. PubMed ID: 35264566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
    Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
    Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
    Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
    Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.
    Renner W; Köppel H; Brodmann M; Pabst E; Schallmoser K; Toplak H; Wascher TC; Pilger E
    Thromb Haemost; 2000 Jan; 83(1):20-2. PubMed ID: 10669148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I; Battaglioli T; Razzari C; Mannucci PM
    J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.